Atara Biotherapeutics, Inc.·4

Mar 3, 5:16 PM ET

Touchon Pascal 4

4 · Atara Biotherapeutics, Inc. · Filed Mar 3, 2023

Insider Transaction Report

Form 4
Period: 2023-03-01
Transactions
  • Award

    Common Stock

    2023-03-01+324,711766,407 total
  • Award

    Employee Stock Option (Right to Buy)

    2023-03-01+730,600730,600 total
    Exercise: $3.91Exp: 2033-02-28Common Stock (730,600 underlying)
Footnotes (2)
  • [F1]These restricted stock units vest in 12 equal quarterly installments on each Company Quarterly Vesting Date (as defined below), with the initial installment vesting on May 15, 2023, subject to the reporting person's continuous service. "Company Quarterly Vesting Date" means March 1, May 15, August 15 and November 15 of each year.
  • [F2]1/36th of the shares subject to the stock option vest and become exercisable each month, with the initial installment vesting on April 1, 2023, subject to the reporting person's continuous service.

Documents

1 file
  • 4
    form4.xmlPrimary